Research by Rabold et al. shows that patients with advanced metastatic thyroid cancer have significantly lower levels of CD3+, CD4+, and CD8+ T cells, underscoring the urgent need for strategies to boost T cell activity against cancer [59]. This evidence concerns the gene CD4 and cancer.